COCP
Price
$1.61
Change
-$0.02 (-1.23%)
Updated
Jun 9, 12:53 PM (EDT)
Capitalization
16.58M
SGMO
Price
$0.52
Change
-$0.01 (-1.89%)
Updated
Jun 9, 03:08 PM (EDT)
Capitalization
130.06M
64 days until earnings call
Interact to see
Advertisement

COCP vs SGMO

Header iconCOCP vs SGMO Comparison
Open Charts COCP vs SGMOBanner chart's image
Cocrystal Pharma
Price$1.61
Change-$0.02 (-1.23%)
Volume$100
Capitalization16.58M
Sangamo Therapeutics
Price$0.52
Change-$0.01 (-1.89%)
Volume$400
Capitalization130.06M
COCP vs SGMO Comparison Chart
Loading...
COCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COCP vs. SGMO commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COCP is a Buy and SGMO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (COCP: $1.43 vs. SGMO: $0.45)
Brand notoriety: COCP and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COCP: 94% vs. SGMO: 25%
Market capitalization -- COCP: $16.58M vs. SGMO: $130.06M
COCP [@Biotechnology] is valued at $16.58M. SGMO’s [@Biotechnology] market capitalization is $130.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COCP’s FA Score shows that 0 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • COCP’s FA Score: 0 green, 5 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, both COCP and SGMO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COCP’s TA Score shows that 2 TA indicator(s) are bullish while SGMO’s TA Score has 4 bullish TA indicator(s).

  • COCP’s TA Score: 2 bullish, 7 bearish.
  • SGMO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SGMO is a better buy in the short-term than COCP.

Price Growth

COCP (@Biotechnology) experienced а 0.00% price change this week, while SGMO (@Biotechnology) price change was -9.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

SGMO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMO($130M) has a higher market cap than COCP($16.6M). COCP YTD gains are higher at: -29.208 vs. SGMO (-55.676). COCP has higher annual earnings (EBITDA): -20.31M vs. SGMO (-89.09M). SGMO has more cash in the bank: 41.9M vs. COCP (13M). COCP has less debt than SGMO: COCP (1.88M) vs SGMO (30.6M). SGMO has higher revenues than COCP: SGMO (57.8M) vs COCP (0).
COCPSGMOCOCP / SGMO
Capitalization16.6M130M13%
EBITDA-20.31M-89.09M23%
Gain YTD-29.208-55.67652%
P/E RatioN/AN/A-
Revenue057.8M-
Total Cash13M41.9M31%
Total Debt1.88M30.6M6%
FUNDAMENTALS RATINGS
COCP vs SGMO: Fundamental Ratings
COCP
SGMO
OUTLOOK RATING
1..100
557
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
8796
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COCP's Valuation (69) in the Pharmaceuticals Generic industry is in the same range as SGMO (79) in the Biotechnology industry. This means that COCP’s stock grew similarly to SGMO’s over the last 12 months.

COCP's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as SGMO (100) in the Biotechnology industry. This means that COCP’s stock grew similarly to SGMO’s over the last 12 months.

COCP's SMR Rating (98) in the Pharmaceuticals Generic industry is in the same range as SGMO (99) in the Biotechnology industry. This means that COCP’s stock grew similarly to SGMO’s over the last 12 months.

COCP's Price Growth Rating (87) in the Pharmaceuticals Generic industry is in the same range as SGMO (96) in the Biotechnology industry. This means that COCP’s stock grew similarly to SGMO’s over the last 12 months.

COCP's P/E Growth Rating (98) in the Pharmaceuticals Generic industry is in the same range as SGMO (100) in the Biotechnology industry. This means that COCP’s stock grew similarly to SGMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COCPSGMO
RSI
ODDS (%)
Bearish Trend 13 days ago
90%
Bullish Trend 13 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 13 days ago
77%
Momentum
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 13 days ago
85%
MACD
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 13 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 13 days ago
90%
Advances
ODDS (%)
Bullish Trend about 1 month ago
83%
Bullish Trend 20 days ago
74%
Declines
ODDS (%)
Bearish Trend 22 days ago
88%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
90%
Bullish Trend 13 days ago
73%
Aroon
ODDS (%)
N/A
Bearish Trend 13 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

COCP and

Correlation & Price change

A.I.dvisor tells us that COCP and SGMO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COCP and SGMO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COCP
1D Price
Change %
COCP100%
+0.70%
SGMO - COCP
28%
Poorly correlated
-0.22%
INM - COCP
25%
Poorly correlated
-5.40%
QSI - COCP
24%
Poorly correlated
-7.29%
TRAW - COCP
23%
Poorly correlated
-3.57%
GSGTF - COCP
23%
Poorly correlated
N/A
More

SGMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with XNCR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
-0.22%
XNCR - SGMO
38%
Loosely correlated
-2.58%
XENE - SGMO
35%
Loosely correlated
-3.29%
ANIX - SGMO
31%
Poorly correlated
+1.60%
VRDN - SGMO
31%
Poorly correlated
-3.09%
AMLX - SGMO
31%
Poorly correlated
+1.48%
More